// App-Quantinova.ai

TCT-238 : Low Event Rates At Long-term Follow-up In The Randomized Myocardial Infarction XAMI Trial Comparing First And Second Generation Drug Eluting Stents

Researchers

Presenter

  • S.H. Hofma

Principal Investigators

  • Pieter C. Smits

  • Arnoud va-t Hof

  • M.A. Velders

  • A.J. van Boven

Medical Centers

  • Maasstad Hospital Rotterdam, Rotterdam, Netherlands

  • Leiden University Medical Centre, Leiden, Netherlands

  • Medical Center Leeuwarden, Leeuwarden, Netherlands

  • Isala Clinics, Zwolle, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved